What is Oncolytics Biotech Inc?
, a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal ("GI") tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 48.51M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 0 | 215,050 shares $15k |
| 9-12months | 0 | 12389,232 shares $348k |